Veterinary Clinical Research Associate - US Clinical Operations
About the job
- Educational Background: Minimum: Bachelor's degree
- Five years’ experience as a clinical study coordinator/monitor or in research in the animal health pharmaceutical industry
- Previous experience working with veterinary clinics and/or research facilities
- Understanding of Good Clinical Practice and/or Good Laboratory Practices
- Previous experience with preparation of regulatory submissions for FDA, EPA and/or EMA for product registration
- Ability to work both as a member of a team and independently in a self-directed and self-motivated manner
- Excellent skills in organizing, planning, time management, quality, attention to detail
- Well-developed critical thinking skills with the ability to learn on the fly and solve problems
- Excellent interpersonal skills with very good written and oral communication skills
- Competence with Microsoft Office Products (Outlook, Word, Excel, PowerPoint and MS Teams)
- Competence with electronic data capture, eClinical software or remote communication tools
- Coordinate or lead the coordination of all study activities, including start up, Investigator training, conduct, site monitoring and close out
- Prepare study protocols, amendments, deviations, data capture forms, electronic data capture systems, test article documentation and study reports
- Collaborate with multiple internal partner groups to plan, coordinate, conduct, analyze, and report studies
- Develop training materials and conduct training of Investigators and other study site personnel
- Serve as the principal communication link between the Sponsor and study sites
- Maintain study files in accordance with SOPs and regulatory requirements
- Implement and execute data management processes including paper and electronic data capture, entry, review, tracking and verification utilizing electronic tools and centralized data management systems
- Prepare study files for submission to regulatory agencies
- Lead multi-functional team(s) and may serve as a project team member or clinical team leader
- Coordinate animal related study activities (i.e. clinical sampling, test material administration and clinical observations)
- Travel: approximately 10 – 40% on an annual basis. Variable, depending upon project status.
- Experience in the study design and execution of field-based companion animal clinical field studies
- Experience as a licensed or registered veterinary technician
- Experience and interest in the conduct and leadership of companion animal clinical field studies
- Expertise in the recruitment of veterinarians to participate in companion animal clinical field studies
- Experience with database configuration and management
- Education and clinical experience in the field of veterinary technology
- Experience conducting/monitoring studies to Good Clinical Practice and/or Good Laboratory Practice standards
- Experience in configuring studies in an electronic data capture platform/ eClinical software
- Knowledge of and exposure to using AI tools
About the company
Zoetis creates medicines and vaccines to protect the health of companion animals and livestock. Its products include vaccines, anti-infectives, parasiticides, dermatology and other therapeutics, medicated feed additives, and diagnostics, sold through veterinarians, livestock producers, and pet owners. The company reaches customers in more than 100 countries and relies on big R&D and a global marketing network to bring new solutions to market. Its goal is to improve animal health worldwide by delivering science-based products and services that help care for animals and prevent disease.
Company Size
10,001+
Company Stage
IPO
Headquarters
Parsippany-Troy Hills, New Jersey
Founded
1952
Get referred to Zoetis Services
See people who can refer or advise you
Simplify's Take
What believers are saying
- FDA granted Simparica Trio EUA on August 13, 2026 for screwworm in dogs.
- Livestock revenue grew double digits in 2026, led by cattle, poultry, and fish.
- Lenivia and Portela launches in Canada and Europe expand osteoarthritis pain coverage.
What critics are saying
- U.S. companion-animal revenue fell 7% in Q2 2026 as clinic visits weakened.
- Elanco and Merck are squeezing Apoquel and Simparica with promotions through 2027.
- If dermatology share keeps eroding, Zoetis becomes a slower livestock-and-diagnostics utility.
What makes Zoetis Services unique
- Zoetis dominates veterinary channels with a broad companion-animal and livestock portfolio.
- Its pipeline spans renal disease, oncology, cardiology, and dermatology, unlike commodity peers.
- Global reach across 100-plus countries gives Zoetis pricing power and distribution leverage.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
401(k) Retirement Plan
Paid Vacation
Paid Holidays
Hybrid Work Options
Growth & Insights and Company News
6 month growth
13%1 year growth
15%2 year growth
15%Zoetis has appointed Iris Knobloch to its board of directors, effective December 1, 2026. The appointment raises the animal health company's board from 12 to 13 members. Knobloch has been president of the Festival de Cannes since July 2022. She chairs the board of music streaming platform Deezer and also sits on the boards of Lazard and Vail Resorts. She previously held senior roles at WarnerMedia. Chief executive officer Kristin Peck said Knobloch's experience in consumer strategy, digital transformation, and regulatory environments will help as Zoetis explores new ways to connect with pet owners.
Zoetis named in Fortune Europe's 100 Best Companies to Work for in 2026. Animal health firm becomes the only sector specialist to feature in the 2026 European workplace rankings Latest Podcast Episode On this episode of Talking Shop Pet Gazette is joined by Scott Erickson, VP of Sales, US and Global Channels at HappyOrNot. HappyOrNot captures real-time, point-of-experience micro-feedback across thousands of global retail environments. Drawing on insights from their Q2 2026 Retail CX Pulse report, Scott joins Pet Gazette to challenge traditional ways of measuring customer satisfaction. Animal health company Zoetis has been named one of Fortune Europe's 100 Best Companies to Work for in 2026, becoming the only dedicated animal health company included on the list. The ranking is compiled by Great Place To Work and Fortune Europe using employee survey responses and information provided by companies on their workplace programmes and strategies. For the opportunity to appear on the list, companies are assessed on factors including trust in leadership, meaningful work, fairness in pay and promotion as well as opportunities for professional development. Zoetis' inclusion follows its recognition in national Best Workplace lists, which made the company eligible for the European ranking. Julia von Gablenz, regional president, Europe and Middle East, Zoetis said: "Zoetis is committed to supporting a workplace where colleagues can thrive and achieve their potential. I am incredibly proud that Zoetis has been recognised as a Fortune Best Company to Work For in Europe. "This achievement belongs to all of our colleagues, whose hard work, passion and commitment create the culture we are so proud of. Every day, in every role, colleagues drive our purpose and business forward. Being part of the list is a testament to Zoetis' inclusive and supportive workplace culture that promotes employee well-being, growth and collaboration." Published: 1h ago
Seven major S&P 500 companies with market capitalizations exceeding $20 billion need to rally at least 200% to reach their previous all-time highs, according to Bespoke. The struggling firms include PG&E, PayPal, Ford, Nike, Las Vegas Sands, Zoetis, and Crown Castle. Nike has experienced particularly poor performance, with the company's stock trading at record lows and its dividend yield approaching 5%. Recent quarterly results showed Nike Brand sales fell 4%, online sales dropped 13%, Converse sales declined 28%, and China sales crashed 26%. CEO Elliott Hill indicated that weakness in the sportswear market would persist. PayPal faces intense competition in the payments sector. New CEO Enrique Lores reportedly declined a buyout offer from Stripe and will focus on cost reductions and improving customer experience.
CooperVision appoints new global director for global myopia management. 22 September 2026 Chris Dimmack joins CooperVision as senior director, global myopia management, moving from Zoetis, where he was head of sales. He previously spent close to 18 years at Johnson & Johnson, most recently as commercial business manager. Jennifer Lambert, who held the same position at CooperVision, was promoted to the vice... Subscribe today. Buying a membership today will give you: * Unlimited access to ewintelligence.com - all insight and analysis available online * Its executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry * Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments * Case studies and best practices on business challenges * Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry * Access to over 11,500 articles and analyses in the archive * Personal library to save articles and track your key content * Powerful search and intuitive navigation * Organisation-wide access across offices, people and devices
The AVA secures $150,000 Zoetis Foundation grant. The Australian Veterinary Association (AVA) has received a USD $150,000 grant from the Zoetis Foundation to expand its Cultivating Safe Teams program nationwide. The funding will support the AVA's goal of training every veterinary professional in Australia to identify and manage psychosocial risks in the workplace. More than 1,300 veterinary professionals have completed the training since it launched in 2023. Cultivating Safe Teams is the flagship program under the AVA's THRIVE wellbeing initiative, which targets psychological harm in veterinary workplaces. Dr Diana Barker, President of the AVA, said the grant would allow the organisation to broaden the program's reach. "Veterinary teams do extraordinary work under real pressure, and for too long the toll of that pressure has gone unaddressed. "This grant enables us to take a program that works and put it in front of every veterinary professional in the country." The program grew out of the AVA's 2021 Veterinary Stakeholder Wellness Survey, which found two in three veterinary professionals had experienced a mental health condition, and almost half said their work was harming their mental health. Cultivating Safe Teams runs as a one-hour awareness session built around evidence-based workplace psychological health and safety frameworks, designed to fit around busy clinic schedules. Among participants, 93 per cent rated the session useful and 94 per cent rated it relevant, while confidence in identifying psychosocial hazards rose by 60 per cent. Dr Barker explained that proactive management of psychosocial risk is now the law in every Australian jurisdiction, so there has never been a more important time to act. "This is about more than compliance. It is about building workplaces where people are safe, supported and want to stay, and that is good for our people, our patients and the future of the profession." The AVA is now expanding the program beyond awareness-raising with a new offering, CST ACTION, which trains workplace champions to run a validated risk assessment and design initiatives tailored to their own hazard profile. The offering includes coaching from organisational psychologists, self-paced modules and peer-to-peer learning. Expressions of interest for the 2027 program are open now on the AVA website. Jeannette Ferran Astorga, Executive Vice President of Corporate Affairs at Zoetis and President of the Zoetis Foundation, said the funding reflected the company's commitment to the sector. "The veterinary profession is foundational to animal health, and the professionals caring for animals deserve workplaces that protect their wellbeing. "We are proud to support the AVA in scaling a program that is already making a measurable difference to veterinary teams across Australia." Cultivating Safe Teams is delivered with support from the Zoetis Foundation, Crampton Consulting Group, Hill's Pet Nutrition and Troy.